Status:

COMPLETED

Augmenting Referral Pathway to Improve Uptake of Retinal Services by Diabetic Patients

Lead Sponsor:

Seva Foundation

Collaborating Sponsors:

Reiyukai Eiko Masunaga Eye Hospital (REMEH)

Indian Institute of Public Health, India

Conditions:

Diabetic Retinopathy

Eligibility:

All Genders

20+ years

Phase:

NA

Brief Summary

Reiyukai Eiko Masunaga Eye Hospital (REMEH) is a non-profitable organization. Retina services were resumed from October 2019. Until this retinal service started, it has been mostly cataract-focused. P...

Detailed Description

Diabetes Mellitus (DM) is a chronic, metabolic disease characterized by elevated levels of blood glucose (or blood sugar), which leads over time to serious damage to the heart, blood vessels, eyes, ki...

Eligibility Criteria

Inclusion

  • Complete enumerations of all Health Personnel treating patients with Diabetes.

Exclusion

  • Health Personnel who are not directly linked with treating patients with Diabetes.
  • Health personnel not willing to participate in the study

Key Trial Info

Start Date :

February 26 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 30 2021

Estimated Enrollment :

19 Patients enrolled

Trial Details

Trial ID

NCT04829084

Start Date

February 26 2021

End Date

December 30 2021

Last Update

March 10 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Reiyukai Eiko Masunaga Eye Hospital (REMEH)

Banepa, Nepal